Polymorphous low grade adenocarcinoma - A clinicopathologic study of 164 cases

Citation
Jt. Castle et al., Polymorphous low grade adenocarcinoma - A clinicopathologic study of 164 cases, CANCER, 86(2), 1999, pp. 207-219
Citations number
38
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER
ISSN journal
0008543X → ACNP
Volume
86
Issue
2
Year of publication
1999
Pages
207 - 219
Database
ISI
SICI code
0008-543X(19990715)86:2<207:PLGA-A>2.0.ZU;2-8
Abstract
BACKGROUND. Polymorphous low grade adenocarcinomas (PLGA) are minor salivar y gland neoplasms with a predilection for intraoral sites. METHODS. One hundred sixty-four cases of PLGA diagnosed between 1970-1994 w ere retrieved from the files of the Armed Forces Institute of Pathology, Wa shington, DC. Histologic features were reviewed, immunohistochemical studie s and prognostic markers were performed, and patient follow-up was obtained . The data were analyzed statistically. RESULTS. The patients included 109 women and 55 men, ages 23-94 years (aver age, 57.6 years). The patients usually presented clinically with a palatal mass that ranged in size from 0.4-6 cm (average, 2.2 cm). The tumors were i nfiltrative and characterized by a polymorphous growth pattern, with indivi dual tumors demonstrating multiple patterns, including solid, ductotubular, cribriform, trabecular, and single file growth. Neurotropism was identifie d frequently. The neoplastic cells were isomorphic with vesicular nuclei. M itotic activity was inconspicuous. At an average of 115.4 months after pres entation, approximately 97.6% of all patients were either alive or had died without evidence of recurrent disease after treatment with surgical excisi on only. Four patients had evidence of disease at last follow-up; three had died with evidence of tumor, and one patient was alive with tumor. CONCLUSIONS. PLGA is a neoplasm of minor salivary gland origin that must be separated from adenoid cystic carcinoma and benign mixed tumor for therape utic and prognostic considerations. Conservative but complete surgical exci sion is the treatment of choice for these slow-growing tumors with a low pr oliferation index; adjuvant therapy does not appear to alter the prognosis. Cancer 1999;86:207-19. (C) 1999 American Cancer Society.